Mackenzie Financial’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,498
Closed -$235K 1584
2023
Q4
$235K Sell
14,498
-2,542
-15% -$41.6K ﹤0.01% 1262
2023
Q3
$199K Buy
+17,040
New +$253K ﹤0.01% 1279
2022
Q1
Sell
-6,278
Closed -$214K 1471
2021
Q4
$214K Sell
6,278
-444
-7% -$17.4K ﹤0.01% 1308
2021
Q3
$324K Buy
+6,722
New +$311K ﹤0.01% 1102
2020
Q3
Sell
-8,450
Closed -$262K 1030
2020
Q2
$262K Sell
8,450
-3,060
-27% -$84.8K ﹤0.01% 896
2020
Q1
$318K Sell
11,510
-840
-7% -$25.2K ﹤0.01% 891
2019
Q4
$361K Sell
12,350
-12,850
-51% -$306K ﹤0.01% 922
2019
Q3
$482K Sell
25,200
-11,300
-31% -$265K ﹤0.01% 828
2019
Q2
$801K Buy
36,500
+24,850
+213% +$545K ﹤0.01% 785
2019
Q1
$238K Buy
+11,650
New +$202K ﹤0.01% 1142

Other funds holding NEO

Mackenzie Financial's NEO Position: Q1 2024 in Review

Mackenzie Financial sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 14,498 shares — an estimated $235K sold.

Mackenzie Financial first reported a position in NEO in Q1 2019 and held it in 10 quarters. The position peaked at $801K in Q2 2019. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Mackenzie Financial reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Mackenzie Financial sold 14,498 NeoGenomics shares in Q1 2024, an estimated $235K.
  • Mackenzie Financial first reported a position in NeoGenomics in Q1 2019 and held it in 10 quarters.
  • Mackenzie Financial's NeoGenomics position peaked at $801K in Q2 2019.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.